Bristol Myers Squibb Research and Development Expenses 2010-2023 | BMY

Bristol Myers Squibb annual/quarterly research and development expenses history and growth rate from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Bristol Myers Squibb research and development expenses for the quarter ending December 31, 2023 were $2.478B, a 1.27% decline year-over-year.
  • Bristol Myers Squibb research and development expenses for the twelve months ending December 31, 2023 were $9.299B, a 2.21% decline year-over-year.
  • Bristol Myers Squibb annual research and development expenses for 2023 were $9.299B, a 2.21% decline from 2022.
  • Bristol Myers Squibb annual research and development expenses for 2022 were $9.509B, a 6.73% decline from 2021.
  • Bristol Myers Squibb annual research and development expenses for 2021 were $10.195B, a 1.46% increase from 2020.
Bristol Myers Squibb Annual Research and Development Expenses
(Millions of US $)
2023 $9,299
2022 $9,509
2021 $10,195
2020 $10,048
2019 $6,148
2018 $6,332
2017 $6,468
2016 $5,012
2015 $5,920
2014 $4,534
2013 $3,731
2012 $3,904
2011 $3,839
2010 $3,566
2009 $3,647
Bristol Myers Squibb Quarterly Research and Development Expenses
(Millions of US $)
2023-12-31 $2,478
2023-09-30 $2,242
2023-06-30 $2,258
2023-03-31 $2,321
2022-12-31 $2,510
2022-09-30 $2,418
2022-06-30 $2,321
2022-03-31 $2,260
2021-12-31 $2,518
2021-09-30 $2,980
2021-06-30 $2,478
2021-03-31 $2,219
2020-12-31 $2,655
2020-09-30 $2,499
2020-06-30 $2,522
2020-03-31 $2,372
2019-12-31 $2,097
2019-09-30 $1,378
2019-06-30 $1,325
2019-03-31 $1,348
2018-12-31 $1,367
2018-09-30 $1,280
2018-06-30 $2,435
2018-03-31 $1,250
2017-12-31 $1,925
2017-09-30 $1,561
2017-06-30 $1,679
2017-03-31 $1,303
2016-12-31 $1,472
2016-09-30 $1,138
2016-06-30 $1,266
2016-03-31 $1,136
2015-12-31 $1,916
2015-09-30 $1,132
2015-06-30 $1,856
2015-03-31 $1,016
2014-12-31 $1,189
2014-09-30 $983
2014-06-30 $1,416
2014-03-31 $946
2013-12-31 $957
2013-09-30 $893
2013-06-30 $951
2013-03-31 $930
2012-12-31 $1,082
2012-09-30 $951
2012-06-30 $962
2012-03-31 $909
2011-12-31 $1,008
2011-09-30 $973
2011-06-30 $923
2011-03-31 $935
2010-12-31 $1,010
2010-09-30 $824
2010-06-30 $822
2010-03-31 $910
2009-12-31 $1,108
2009-09-30 $820
2009-06-30 $811
2009-03-31 $908
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $107.925B $45.006B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $153.434B 15.35
Vertex Pharmaceuticals (VRTX) United States $107.797B 31.05
Regeneron Pharmaceuticals (REGN) United States $106.063B 25.71
Gilead Sciences (GILD) United States $90.903B 10.86
CSL (CSLLY) Australia $90.736B 0.00
GSK (GSK) United Kingdom $88.488B 11.17
Moderna (MRNA) United States $42.343B 0.00
Biogen (BIIB) United States $31.447B 14.69
Argenex SE (ARGX) Netherlands $23.637B 0.00
BioNTech SE (BNTX) Germany $22.101B 22.57
Illumina (ILMN) United States $22.036B 159.40
Genmab (GMAB) Denmark $20.239B 25.96
Alnylam Pharmaceuticals (ALNY) United States $19.445B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.719B 70.89
BeiGene (BGNE) Cayman Islands $14.822B 0.00
Incyte (INCY) United States $12.825B 21.31
Sarepta Therapeutics (SRPT) United States $12.229B 0.00
Exact Sciences (EXAS) United States $12.141B 0.00
Bio-Techne Corp (TECH) United States $10.912B 40.60
Repligen (RGEN) United States $10.304B 106.79
QIAGEN (QGEN) Netherlands $9.756B 20.19
Bio-Rad Laboratories (BIO.B) United States $9.474B 28.22
Legend Biotech (LEGN) United States $9.397B 0.00
Roivant Sciences (ROIV) United Kingdom $8.735B 0.00
Ascendis Pharma (ASND) Denmark $8.566B 0.00
Viking Therapeutics (VKTX) United States $8.375B 0.00
Vaxcyte (PCVX) United States $7.426B 0.00
Cytokinetics (CYTK) United States $7.356B 0.00
Exelixis (EXEL) United States $7.234B 37.28
Apellis Pharmaceuticals (APLS) United States $7.053B 0.00
Intra-Cellular Therapies (ITCI) United States $6.749B 0.00
Blueprint Medicines (BPMC) United States $5.801B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.632B 0.00
Halozyme Therapeutics (HALO) United States $5.175B 15.97
Zealand Pharma (ZLDPF) Denmark $5.125B 0.00
Krystal Biotech (KRYS) United States $5.013B 0.00
Nuvalent (NUVL) United States $4.910B 0.00
Immunovant (IMVT) United States $4.725B 0.00
Biohaven (BHVN) United States $4.653B 0.00
Alkermes (ALKS) Ireland $4.553B 24.33
Insmed (INSM) United States $4.057B 0.00
Apogee Therapeutics (APGE) United States $3.981B 0.00
Iovance Biotherapeutics (IOVA) United States $3.938B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.853B 0.00
Axsome Therapeutics (AXSM) United States $3.751B 0.00
Arcellx (ACLX) United States $3.720B 0.00
SpringWorks Therapeutics (SWTX) United States $3.697B 0.00
ImmunityBio (IBRX) United States $3.680B 0.00
Fortrea Holdings (FTRE) United States $3.583B 0.00
Amicus Therapeutics (FOLD) United States $3.503B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.244B 0.00
IDEAYA Biosciences (IDYA) United States $3.229B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.208B 0.00
Immunocore Holdings (IMCR) United Kingdom $3.168B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.999B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.936B 0.00
Denali Therapeutics (DNLI) United States $2.890B 0.00
Certara (CERT) United States $2.817B 60.76
Arvinas (ARVN) United States $2.814B 0.00
Beam Therapeutics (BEAM) United States $2.773B 0.00
MorphoSys AG (MOR) Germany $2.732B 0.00
CG Oncology (CGON) United States $2.732B 0.00
Intellia Therapeutics (NTLA) United States $2.597B 0.00
Merus (MRUS) Netherlands $2.590B 0.00
Vericel (VCEL) United States $2.532B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.513B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.466B 0.00
Kymera Therapeutics (KYMR) United States $2.455B 0.00
Ginkgo Bioworks Holdings (DNA) United States $2.368B 0.00
Celldex Therapeutics (CLDX) United States $2.336B 0.00
Keros Therapeutics (KROS) United States $2.327B 0.00
Vera Therapeutics (VERA) United States $2.301B 0.00
Sana Biotechnology (SANA) United States $2.204B 0.00
Guardant Health (GH) United States $2.186B 0.00
Galapagos (GLPG) Belgium $2.171B 0.00
Neumora Therapeutics (NMRA) United States $2.004B 0.00
Structure Therapeutics (GPCR) United States $2.000B 0.00
Twist Bioscience (TWST) United States $1.994B 0.00
Avidity Biosciences (RNA) United States $1.967B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.960B 0.00
Janux Therapeutics (JANX) United States $1.959B 0.00
NeoGenomics (NEO) United States $1.940B 0.00
Myriad Genetics (MYGN) United States $1.923B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.903B 15.81
Geron (GERN) United States $1.807B 0.00
Bavarian Nordic (BVNRY) Denmark $1.747B 5.74
Morphic Holding (MORF) United States $1.721B 0.00
Edgewise Therapeutics (EWTX) United States $1.672B 0.00
Inhibrx (INBX) United States $1.666B 0.00
Protagonist Therapeutics (PTGX) United States $1.660B 0.00
Arcus Biosciences (RCUS) United States $1.655B 0.00
Kura Oncology (KURA) United States $1.612B 0.00
Dynavax Technologies (DVAX) United States $1.605B 0.00
Zai Lab (ZLAB) China $1.600B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.571B 0.00
ADMA Biologics Inc (ADMA) United States $1.538B 0.00
ANI Pharmaceuticals (ANIP) United States $1.469B 18.05
Disc Medicine (IRON) United States $1.461B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.449B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.412B 0.00
Immunome (IMNM) United States $1.397B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.380B 0.00
Akero Therapeutics (AKRO) United States $1.376B 0.00
Vir Biotechnology (VIR) United States $1.364B 0.00
Prothena (PRTA) Ireland $1.352B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.319B 0.00
AbCellera Biologics (ABCL) Canada $1.315B 0.00
Ligand Pharmaceuticals (LGND) United States $1.262B 15.63
MannKind (MNKD) United States $1.252B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.227B 0.00
Scholar Rock Holding (SRRK) United States $1.203B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.183B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.181B 0.00
Belite Bio (BLTE) United States $1.164B 0.00
Liquidia Technologies (LQDA) United States $1.146B 0.00
MiMedx (MDXG) United States $1.118B 253.67
Viridian Therapeutics (VRDN) United States $1.099B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $1.078B 0.00
89BIO (ETNB) United States $1.058B 0.00
Kyverna Therapeutics (KYTX) United States $1.040B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.037B 0.00
REGENXBIO (RGNX) United States $0.985B 0.00
Immatics (IMTX) Germany $0.940B 0.00
Abivax SA (ABVX) France $0.931B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.928B 0.00
Oric Pharmaceuticals (ORIC) United States $0.907B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.884B 0.00
CARGO Therapeutics (CRGX) United States $0.882B 0.00
Pliant Therapeutics (PLRX) United States $0.876B 0.00
Cytek Biosciences (CTKB) United States $0.867B 0.00
Nuvation Bio (NUVB) United States $0.866B 0.00
Tyra Biosciences (TYRA) United States $0.856B 0.00
Cabaletta Bio (CABA) United States $0.827B 0.00
Tango Therapeutics (TNGX) United States $0.822B 0.00
Prime Medicine (PRME) United States $0.811B 0.00
Aerovate Therapeutics (AVTE) United States $0.794B 0.00
Praxis Precision Medicines (PRAX) United States $0.784B 0.00
Pharming Group (PHGUF) Netherlands $0.783B 0.00
HilleVax (HLVX) United States $0.776B 0.00
PureTech Health (PRTC) United States $0.774B 0.00
Cullinan Oncology (CGEM) United States $0.764B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.756B 0.00
Allogene Therapeutics (ALLO) United States $0.754B 0.00
EnGene Holdings (ENGN) United States $0.751B 0.00
Astria Therapeutics (ATXS) United States $0.747B 0.00
WAVE Life Sciences (WVE) Singapore $0.739B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.738B 0.00
Fate Therapeutics (FATE) United States $0.728B 0.00
Pharming Group (PHAR) Netherlands $0.727B 0.00
Zymeworks (ZYME) United States $0.727B 0.00
Applied Therapeutics (APLT) United States $0.725B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.722B 0.00
Northwest Biotherapeutics (NWBO) United States $0.716B 0.00
Nurix Therapeutics (NRIX) United States $0.711B 0.00
CureVac (CVAC) Germany $0.683B 0.00
Novavax (NVAX) United States $0.679B 0.00
Cogent Biosciences (COGT) United States $0.678B 0.00
ACELYRIN, INC (SLRN) United States $0.657B 0.00
Stoke Therapeutics (STOK) United States $0.656B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.646B 0.00
Mineralys Therapeutics (MLYS) United States $0.634B 0.00
Neurogene (NGNE) United States $0.633B 0.00
Olema Pharmaceuticals (OLMA) United States $0.626B 0.00
Absci (ABSI) United States $0.625B 0.00
Editas Medicine (EDIT) United States $0.609B 0.00
Fulcrum Therapeutics (FULC) United States $0.586B 0.00
Castle Biosciences (CSTL) United States $0.584B 0.00
Travere Therapeutics (TVTX) United States $0.584B 0.00
Alector (ALEC) United States $0.582B 0.00
ArriVent BioPharma (AVBP) United States $0.575B 0.00
ALX Oncology Holdings (ALXO) United States $0.572B 0.00
AnaptysBio (ANAB) United States $0.572B 0.00
GH Research (GHRS) Ireland $0.557B 0.00
C4 Therapeutics (CCCC) United States $0.552B 0.00
Biomea Fusion (BMEA) United States $0.548B 0.00
Nkarta (NKTX) United States $0.548B 0.00
IGM Biosciences (IGMS) United States $0.545B 0.00
Mersana Therapeutics (MRSN) United States $0.545B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.539B 0.00
Solid Biosciences (SLDB) United States $0.538B 0.00
Voyager Therapeutics (VYGR) United States $0.519B 3.09
Revance Therapeutics (RVNC) United States $0.515B 0.00
Replimune (REPL) United States $0.506B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.483B 0.00
Oculis Holding AG (OCS) Switzerland $0.482B 0.00
Entrada Therapeutics (TRDA) United States $0.482B 0.00
ITeos Therapeutics (ITOS) United States $0.472B 0.00
Arbutus Biopharma (ABUS) United States $0.467B 0.00
Caribou Biosciences (CRBU) United States $0.462B 0.00
Ocugen (OCGN) United States $0.457B 0.00
Inozyme Pharma (INZY) United States $0.456B 0.00
PepGen (PEPG) United States $0.456B 0.00
Dianthus Therapeutics (DNTH) United States $0.453B 0.00
Alto Neuroscience (ANRO) United States $0.451B 0.00
MaxCyte (MXCT) United States $0.450B 0.00
Avid Bioservices (CDMO) United States $0.441B 0.00
Invivyd (IVVD) United States $0.440B 0.00
Celcuity (CELC) United States $0.439B 0.00
Jasper Therapeutics (JSPR) United States $0.434B 0.00
Shattuck Labs (STTK) United States $0.426B 0.00
Adaptive Biotechnologies (ADPT) United States $0.419B 0.00
Annexon (ANNX) United States $0.416B 0.00
Anavex Life Sciences (AVXL) United States $0.415B 0.00
Tenaya Therapeutics (TNYA) United States $0.405B 0.00
MeiraGTx Holdings (MGTX) United States $0.399B 0.00
Terns Pharmaceuticals (TERN) United States $0.398B 0.00
TScan Therapeutics (TCRX) United States $0.397B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.393B 0.00
Kodiak Sciences (KOD) United States $0.391B 0.00
Third Harmonic Bio (THRD) United States $0.386B 0.00
FibroBiologics (FBLG) United States $0.383B 0.00
Anika Therapeutics (ANIK) United States $0.379B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.375B 0.00
Amarin (AMRN) Ireland $0.365B 0.00
Humacyte (HUMA) United States $0.362B 0.00
Precigen (PGEN) United States $0.361B 0.00
Mesoblast (MESO) Australia $0.354B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.353B 0.00
Urogen Pharma (URGN) United States $0.351B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.347B 0.00
Nautilus Biotechnology (NAUT) United States $0.347B 0.00
Ventyx Biosciences (VTYX) United States $0.344B 0.00
Adlai Nortye (ANL) Cayman Islands $0.337B 0.00
Atea Pharmaceuticals (AVIR) United States $0.337B 0.00
Kamada (KMDA) Israel $0.322B 24.35
Erasca (ERAS) United States $0.311B 0.00
Rapt Therapeutics (RAPT) United States $0.311B 0.00
Sutro Biopharma (STRO) United States $0.308B 0.00
Inovio Pharmaceuticals (INO) United States $0.305B 0.00
Adverum Biotechnologies (ADVM) United States $0.304B 0.00
AC Immune (ACIU) Switzerland $0.300B 0.00
Verastem (VSTM) United States $0.299B 0.00
Poseida Therapeutics (PSTX) United States $0.297B 0.00
Aura Biosciences (AURA) United States $0.295B 0.00
Compass Therapeutics (CMPX) United States $0.282B 0.00
ChromaDex (CDXC) United States $0.276B 0.00
2seventy Bio (TSVT) United States $0.276B 0.00
Gritstone Bio (GRTS) United States $0.275B 0.00
Coherus BioSciences (CHRS) United States $0.273B 0.00
Werewolf Therapeutics (HOWL) United States $0.271B 0.00
XOMA (XOMA) United States $0.271B 0.00
Puma Biotechnology (PBYI) United States $0.269B 12.13
Scilex Holding (SCLX) United States $0.268B 0.00
Gossamer Bio (GOSS) United States $0.264B 0.00
UniQure (QURE) Netherlands $0.259B 0.00
Greenwich LifeSciences (GLSI) United States $0.257B 0.00
Cardiff Oncology (CRDF) United States $0.257B 0.00
Codexis (CDXS) United States $0.247B 0.00
23andMe Holding (ME) United States $0.246B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.246B 0.00
Elevation Oncology (ELEV) United States $0.244B 0.00
XBiotech (XBIT) United States $0.243B 0.00
Trevi Therapeutics (TRVI) United States $0.239B 0.00
X4 Pharmaceuticals (XFOR) United States $0.237B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.234B 0.00
G1 Therapeutics (GTHX) United States $0.233B 0.00
Agenus (AGEN) United States $0.233B 0.00
Akoya Biosciences (AKYA) United States $0.232B 0.00
Opthea (OPT) Australia $0.228B 0.00
CorMedix Inc (CRMD) United States $0.228B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.224B 77.80
Design Therapeutics (DSGN) United States $0.221B 0.00
Compugen (CGEN) Israel $0.220B 0.00
Ovid Therapeutics (OVID) United States $0.216B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Prima BioMed (IMMP) Australia $0.210B 0.00
INmune Bio (INMB) United States $0.210B 0.00
Alimera Sciences (ALIM) United States $0.204B 0.00
Abeona Therapeutics (ABEO) United States $0.201B 0.00
Inventiva S.A (IVA) France $0.199B 0.00
Omega Therapeutics (OMGA) United States $0.196B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.194B 0.00
Innate Pharma S.A (IPHA) France $0.192B 0.00
Adicet Bio (ACET) United States $0.191B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.190B 0.00
Renovaro (RENB) United States $0.186B 0.00
GENFIT S.A (GNFT) France $0.182B 0.00
LENZ Therapeutics (LENZ) United States $0.182B 0.00
ScPharmaceuticals (SCPH) United States $0.181B 0.00
Repare Therapeutics (RPTX) Canada $0.173B 0.00
Adocia (ADOCY) France $0.166B 0.00
BioAtla (BCAB) United States $0.166B 0.00
Genelux (GNLX) United States $0.161B 0.00
Lifecore Biomedical (LFCR) United States $0.157B 0.00
Molecular Partners AG (MOLN) Switzerland $0.153B 0.00
Rani Therapeutics Holdings (RANI) United States $0.151B 0.00
I-Mab (IMAB) China $0.151B 0.00
Vor Biopharma (VOR) $0.151B 0.00
Spyre Therapeutics (SYRE) United States $0.150B 0.00
Bluebird Bio (BLUE) United States $0.149B 0.00
Cellectis S.A (CLLS) France $0.148B 0.00
CytomX Therapeutics (CTMX) United States $0.148B 0.00
Nuvectis Pharma (NVCT) United States $0.148B 0.00
DBV Technologies S.A (DBVT) France $0.148B 0.00
BeyondSpring (BYSI) United States $0.141B 0.00
Ocean Biomedical (OCEA) United States $0.138B 0.00
TELA Bio (TELA) United States $0.138B 0.00
ATyr Pharma (LIFE) United States $0.136B 0.00
Emergent Biosolutions (EBS) United States $0.135B 0.00
NGM Biopharmaceuticals (NGM) United States $0.135B 0.00
Vincerx Pharma (VINC) United States $0.130B 0.00
Annovis Bio (ANVS) United States $0.127B 0.00
Genetron Holdings (GTH) China $0.127B 0.00
Seer (SEER) United States $0.126B 0.00
Kinnate Biopharma (KNTE) United States $0.125B 0.00
Clearside Biomedical (CLSD) United States $0.125B 0.00
VistaGen Therapeutics (VTGN) United States $0.124B 0.00
Syros Pharmaceuticals (SYRS) United States $0.123B 0.00
Sagimet Biosciences (SGMT) United States $0.122B 0.00
Oncobiologics (OTLK) United States $0.122B 0.00
PDS Biotechnology (PDSB) United States $0.120B 0.00
Vigil Neuroscience (VIGL) United States $0.118B 0.00
Seres Therapeutics (MCRB) United States $0.118B 0.00
Immunic (IMUX) United States $0.117B 0.00
IO Biotech (IOBT) Denmark $0.114B 0.00
Adagene (ADAG) China $0.113B 0.00
Allakos (ALLK) United States $0.112B 0.00
Sangamo Therapeutics (SGMO) United States $0.112B 0.00
CervoMed (CRVO) United States $0.111B 0.00
Cartesian Therapeutics (RNAC) United States $0.107B 0.00
Lantern Pharma (LTRN) United States $0.105B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.103B 0.00
DiaMedica Therapeutics (DMAC) United States $0.101B 0.00
Alpha Teknova (TKNO) United States $0.100B 0.00
Zura Bio (ZURA) United States $0.100B 0.00
Athira Pharma (ATHA) United States $0.098B 0.00
Eton Pharmaceuticals (ETON) United States $0.098B 0.00
Coya Therapeutics (COYA) United States $0.097B 0.00
AN2 Therapeutics (ANTX) United States $0.096B 0.00
Celularity (CELU) United States $0.096B 0.00
BioHarvest Sciences (CNVCF) Canada $0.095B 0.00
Spero Therapeutics (SPRO) United States $0.094B 3.50
Barinthus Biotherapeutics (BRNS) United Kingdom $0.090B 0.00
Rezolute (RZLT) United States $0.089B 0.00
Connect Biopharma Holdings (CNTB) United States $0.089B 0.00
BioXcel Therapeutics (BTAI) United States $0.088B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.088B 0.00
Vaxxinity (VAXX) United States $0.087B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.084B 0.00
Cue Biopharma (CUE) United States $0.083B 0.00
Affimed (AFMD) Germany $0.080B 0.00
Oncolytics Biotech (ONCY) Canada $0.078B 0.00
Elutia (ELUT) United States $0.076B 0.00
Cidara Therapeutics (CDTX) United States $0.076B 0.00
Kronos Bio (KRON) United States $0.075B 0.00
Aligos Therapeutics (ALGS) United States $0.074B 0.00
Passage Bio (PASG) United States $0.073B 0.00
Equillium (EQ) United States $0.073B 0.00
Instil Bio (TIL) United States $0.072B 0.00
MediciNova (MNOV) United States $0.072B 0.00
VTv Therapeutics (VTVT) United States $0.072B 0.00
Atara Biotherapeutics (ATRA) United States $0.071B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.071B 0.00
Leap Therapeutics (LPTX) United States $0.071B 0.00
Immuneering (IMRX) United States $0.071B 0.00
Cognition Therapeutics (CGTX) United States $0.071B 0.00
Intensity Therapeutics (INTS) United States $0.069B 0.00
InflaRx (IFRX) Germany $0.069B 0.00
Ikena Oncology (IKNA) United States $0.067B 0.00
Genenta Science S.p.A (GNTA) Italy $0.067B 0.00
Landos Biopharma (LABP) United States $0.067B 0.00
YS Biopharma (YS) China $0.066B 0.00
Kezar Life Sciences (KZR) United States $0.066B 0.00
Turnstone Biologics (TSBX) United States $0.065B 0.00
Enzo Biochem (ENZ) United States $0.065B 0.00
Curis (CRIS) United States $0.064B 0.00
HCW Biologics (HCWB) United States $0.063B 0.00
Elicio Therapeutics (ELTX) United States $0.063B 0.00
Beyond Air (XAIR) United States $0.063B 0.00
Immix Biopharma (IMMX) United States $0.061B 0.00
HOOKIPA Pharma (HOOK) United States $0.060B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.060B 0.00
Rallybio (RLYB) United States $0.060B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.060B 0.00
Bionano Genomics (BNGO) United States $0.060B 0.00
Aadi Bioscience (AADI) United States $0.058B 0.00
AVROBIO (AVRO) United States $0.057B 0.00
Semper Paratus Acquisition (TVGN) United States $0.055B 0.00
Clene (CLNN) United States $0.055B 0.00
Dare Bioscience (DARE) United States $0.054B 0.00
NextCure (NXTC) United States $0.054B 0.00
Precision BioSciences (DTIL) United States $0.053B 0.00
Apollomics (APLM) Taiwan $0.053B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.052B 0.00
Ocuphire Pharma (OCUP) United States $0.050B 0.00
Carmell (CTCX) United States $0.050B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.049B 0.00
Quince Therapeutics (QNCX) United States $0.048B 0.00
Checkpoint Therapeutics (CKPT) United States $0.048B 0.00
Cara Therapeutics (CARA) United States $0.048B 0.00
Dyadic (DYAI) United States $0.047B 0.00
Eyenovia (EYEN) United States $0.047B 0.00
Bolt Biotherapeutics (BOLT) United States $0.047B 0.00
Lexaria Bioscience (LEXX) Canada $0.046B 0.00
Estrella Immunopharma (ESLA) United States $0.046B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.045B 0.00
Gyre Therapeutics (GYRE) United States $0.045B 0.00
Candel Therapeutics (CADL) United States $0.045B 0.00
Entera Bio (ENTX) Israel $0.044B 0.00
OKYO Pharma (OKYO) $0.043B 0.00
BRIACELL THERAP (BCTX) Canada $0.043B 0.00
Cyclo Therapeutics (CYTH) United States $0.040B 0.00
NKGen Biotech (NKGN) United States $0.039B 0.00
IN8bio (INAB) United States $0.039B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.037B 0.00
Pluri (PLUR) Israel $0.036B 0.00
Theratechnologies (THTX) Canada $0.035B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.035B 0.00
Aileron Therapeutics (ALRN) United States $0.034B 0.00
Promis Neurosciences (PMN) Canada $0.033B 0.00
Galena Biopharma (SLS) United States $0.033B 0.00
Prenetics Global (PRE) Cayman Islands $0.033B 39.70
Biora Therapeutics (BIOR) United States $0.032B 0.00
Femasys (FEMY) United States $0.032B 0.00
MiNK Therapeutics (INKT) United States $0.032B 0.00
Spruce Biosciences (SPRB) United States $0.030B 0.00
Evogene (EVGN) Israel $0.030B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.029B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.028B 0.00
UNITY Biotechnology (UBX) United States $0.027B 0.00
Sensei Biotherapeutics (SNSE) United States $0.027B 0.00
Orgenesis (ORGS) United States $0.027B 0.00
Lisata Therapeutics (LSTA) United States $0.027B 0.00
ARCA Biopharma (ABIO) United States $0.025B 0.00
Forte Biosciences (FBRX) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.025B 0.00
CalciMedica (CALC) United States $0.024B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.024B 0.00
Aptose Biosciences (APTO) Canada $0.024B 0.00
Lumos Pharma (LUMO) United States $0.023B 0.00
Aprea Therapeutics (APRE) United States $0.023B 0.00
SAB Biotherapeutics (SABS) United States $0.022B 0.00
Galecto (GLTO) Denmark $0.021B 0.00
KALA BIO (KALA) United States $0.021B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.021B 0.00
Synlogic (SYBX) United States $0.021B 0.00
BioAffinity Technologies (BIAF) United States $0.020B 0.00
Fortress Biotech (FBIO) United States $0.019B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.019B 0.00
TRACON Pharmaceuticals (TCON) United States $0.019B 0.00
Senti Biosciences (SNTI) United States $0.018B 0.00
Xilio Therapeutics (XLO) United States $0.018B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.016B 0.00
NuCana (NCNA) United Kingdom $0.016B 0.00
IMMURON (IMRN) Australia $0.016B 0.00
TFF Pharmaceuticals (TFFP) United States $0.016B 0.00
Purple Biotech (PPBT) Israel $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
Acorda Therapeutics (ACOR) United States $0.015B 0.00
RenovoRx (RNXT) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
VBI Vaccines (VBIV) United States $0.014B 0.00
Telesis Bio (TBIO) United States $0.013B 0.00
Benitec Biopharma (BNTC) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
ABVC BioPharma (ABVC) United States $0.013B 0.00
Moleculin Biotech (MBRX) United States $0.012B 0.00
Evaxion Biotech (EVAX) Denmark $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
Elevai Labs (ELAB) United States $0.012B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.011B 0.00
Genetic Technologies (GENE) Australia $0.011B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.011B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.011B 0.00
Psyence Biomedical (PBM) United States $0.010B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.010B 0.00
Cadrenal Therapeutics (CVKD) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Portage Biotech (PRTG) $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.009B 0.00
Seelos Therapeutics (SEEL) United States $0.009B 0.00
Chemomab Therapeutics (CMMB) Israel $0.009B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Trevena (TRVN) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Galera Therapeutics (GRTX) United States $0.008B 0.00
Atrinsic (PTIX) United States $0.008B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.008B 0.00
Longeveron (LGVN) United States $0.008B 0.00
AquaBounty Technologies (AQB) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Biorestorative Therapies (BRTX) United States $0.007B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Gamida Cell (GMDA) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Pulmatrix (PULM) United States $0.006B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
NexImmune (NEXI) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.37
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Artelo Biosciences (ARTL) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Notable Labs (NTBL) United States $0.004B 0.00
PaxMedica (PXMD) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Kintara Therapeutics (KTRA) United States $0.003B 0.00
Biophytis SA (BPTS) France $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
First Wave BioPharma (FWBI) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
Sunshine Biopharma (SBFM) Canada $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
Tenax Therapeutics (TENX) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Cingulate (CING) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00